Bolt Biotherapeutics (BOLT) support and resistance · rev $7.7M
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
This page maps Bolt Biotherapeutics (BOLT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
BOLT currently screens at market cap $11.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BOLT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BOLT quote page for the session range and the stock page for the full model.
Not investment advice.